top of page

FUTURE OF FUNDS

Join us in redefining investment strategies and exploring new opportunities.

Company Overseas HQ

Our Mission

OPEN ACCESS TO INNOVATION 

Across every sub-fund, we deliver institutional-grade investment theses, transparent reporting, and clear, consistent investor communication. We believe genuine innovation is born of open ecosystems—ones that move freely across borders, institutions, and industries to integrate the very best of knowledge, technology, and capital.

SHAPE RISK, DON'T CHASE IT 

We allocate with discipline across stages and sectors, underwrite against clear milestones, and manage liquidity and risk proactively. Rather than reach for high-risk opportunities, we engineer structure and stage capital deliberately—generating superior returns within a controlled risk envelope.

ANCHORED IN SINGAPORE 

We operate from a trusted, well-regulated global hub, supported by best-in-class governance and administration, and connected efficiently to premium ecosystems and resources. As Asia's most credible financial and innovation centre, Singapore offers our platform an institutional foundation and an international reach that few jurisdictions can match.

INVESTING IN THE ENGINES OF TOMORROW

Anchored in Singapore, we channel global capital into the most compelling ideas and the boldest teams—funding the technologies that will reshape entire industries. What we back is more than commercial opportunity; it is the systemic transformation of healthcare itself.

We are committed to advancing the Singapore Economic Development Board's (EDB) Singapore +1 / SG+ vision: positioning Singapore as the command centre for intellectual property, talent, governance, and capital, while building scalable manufacturing capacity and market access across Southeast Asia's principal markets. This strategy aligns with Singapore's long-term national interests and with the growth ambitions of the companies and investors we serve.

Looking ahead, we are focused on intelligent healthcare, pharmacy automation, life-science platforms, and China–Singapore bilateral industrial collaboration. Through disciplined capital allocation and deep operating capability, we are building durable, defensible competitive advantage across Asia.

Our Vision

bottom of page